Clinical Trial Update: Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 outpatient trial is evaluating ketamine treatment for phantom limb pain, allowing a minimum 7-day remission between sessions, and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phantom Limb Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: The Ketamine Research Foundation | Conditions: Phantom Limb Syndrome With Pain | Phase 2, Phase 3 | Status: RECRUITING